0HF3.L
Cencora
Q3 2025 Report
Cencora (0HF3.L) Q3 2025 Financial Results: Robust Growth Amidst Industry Challenges...
Read full report
Executive Summary
In Q2 2025, Cencora reported a notable revenue of $75.5 billion, with a corresponding net income of $717.9 million, reflecting a significant year-over-year increase of 71% in net income. The company showcased resilience with a gross profit margin of 4.01%, underscoring the effectiveness of its sales strategies despite rising operational costs impacting the healthcare distribution segment. Management attributed this performance to operational efficiencies and strategic market positioning, which enabled the firm to navigate challenging cost environments effectively.
Notably, Cencora experienced a quarter-on-quarter decrease in revenue by approximately 7.4%, which raises questions regarding seasonal demand and the competitive landscape. However, the management’s proactive communication regarding operational strategies to address these fluctuations provides assurance to stakeholders, and the solid growth in net income indicates robust underlying business fundamentals that investors should monitor closely.
Key Performance Indicators
Revenue
75.45B
QoQ: -7.40% | YoY:10.29%
Gross Profit
3.06B
4.06% margin
QoQ: 19.62% | YoY:35.01%
Operating Income
1.04B
QoQ: 46.72% | YoY:18.09%
Net Income
717.87M
QoQ: 46.92% | YoY:70.61%
EPS
3.70
QoQ: 46.83% | YoY:75.36%
Revenue Trend
Margin Analysis
Key Insights
### Financial Performance Metrics **Revenue**: $75.5 billion (YoY: +10.29%, QoQ: -7.40%) **Gross Profit**: $3.06 billion (YoY: +35.01%, QoQ: +19.62%) **Net Income**: $717.9 million (YoY: +70.61%, QoQ: +46.92%) **EPS**: $3.70 (YoY: +75.36%, QoQ: +46.83%) Cencora's revenue growth remains strong on a year-over-year basis, reinforced by a notable increase in net income, showcasing operational scalability. The decrease in revenue from the previous quarter suggests a need for enhanced demand man...